Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies.
epidemiology
incidence
multiple sclerosis
prevalence
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
18 May 2020
18 May 2020
Historique:
received:
14
04
2020
revised:
10
05
2020
accepted:
15
05
2020
entrez:
24
5
2020
pubmed:
24
5
2020
medline:
24
5
2020
Statut:
epublish
Résumé
In the Russian Federation, multiple sclerosis prevalence rates vary from 10 to 80 cases per 100,000, depending on region and the nationality of the population. The main characteristics of multiple sclerosis epidemiology in the XX century in this big territory are: (1) steady increase in multiple sclerosis prevalence and incidence rates, maybe because of better diagnosis and treatment, but also changes in environmental/epigenetic risk profile and/or lifestyle factors; (2) increase of the female to male ratio, increase in multiple sclerosis incidence mainly in females; (3) appearance and increasing frequency of multiple sclerosis in ethnic groups, previously free of multiple sclerosis (Northern Tribes, Yakuts and others). The latest data show that in European Russia, the multiple sclerosis prevalence varies from 30 to 80 cases, in Siberia-from 20 to 70 cases, with steady increases, especially in women.
Identifiants
pubmed: 32443404
pii: brainsci10050305
doi: 10.3390/brainsci10050305
pmc: PMC7288193
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(7 Suppl 2):75-8
pubmed: 19891350
Neurology. 2019 Mar 5;92(10):e1029-e1040
pubmed: 30770430
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):7-11
pubmed: 31156234
Cells. 2019 Feb 08;8(2):
pubmed: 30743997
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(2 Pt 2):5-8
pubmed: 22677672
Ann Neurol. 1983 Mar;13(3):227-31
pubmed: 6847134
Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
Curr Top Behav Neurosci. 2015;26:57-86
pubmed: 25690592
Ann Med Health Sci Res. 2011 Jan;1(1):63-7
pubmed: 23209956
PLoS One. 2012;7(10):e48078
pubmed: 23133550
Neuroepidemiology. 2014;42(3):154-60
pubmed: 24556851
Brain Behav. 2019 Jan;9(1):e01150
pubmed: 30485721
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(3 Pt 1):60-2
pubmed: 22677758
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):6-9
pubmed: 28617355
J Neurol. 2019 Oct;266(10):2376-2386
pubmed: 31187189
Mult Scler. 2014 Dec;20(14):1896-9
pubmed: 25145690
Neurology. 2014 Sep 9;83(11):1022-4
pubmed: 25200713
Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(1):97-9
pubmed: 20443246
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(2):40-4
pubmed: 10709290
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;Spec No 3:17-21
pubmed: 17172230
Mult Scler. 2014 Apr;20(5):543-7
pubmed: 24025709
Autoimmun Rev. 2012 Jun;11(8):604-9
pubmed: 22041580
J Neuroimmunol. 2018 Apr 15;317:67-76
pubmed: 29325906
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10 Pt 2):8-14
pubmed: 24300812
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(2 Pt 2):5-9
pubmed: 24662349
Zh Nevrol Psikhiatr Im S S Korsakova. 2003;(Spec No 2):111-3
pubmed: 12938645
Ther Adv Neurol Disord. 2013 Jul;6(4):237-48
pubmed: 23858327
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;Spec No 3:11-6
pubmed: 17172229
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10 Pt 2):5-7
pubmed: 24300811
Ann N Y Acad Sci. 2018 Apr;1417(1):71-86
pubmed: 29377214
Acta Neurol Scand Suppl. 1995;161:71-6
pubmed: 7653249
Zh Nevrol Psikhiatr Im S S Korsakova. 2002;Suppl:3-6
pubmed: 12418385
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;Spec No 3:22-5
pubmed: 17172231
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;Spec No 3:4-10
pubmed: 17172228